- Q1 2024 Cellectar Biosciences Inc Earnings Call TranscriptMay 14, 2024$3.18 (+3.92%)Earnings
- Q4 2023 Cellectar Biosciences Inc Earnings Call TranscriptMar 27, 2024$3.64 (-5.58%)Earnings
- Cellectar Biosciences Inc KOL Call TranscriptJan 19, 2024
- Cellectar Biosciences Inc at EBD Group Biotech Showcase TranscriptJan 09, 2024
- Cellectar Biosciences Inc Top-line Data Call TranscriptJan 08, 2024
- Q3 2023 Cellectar Biosciences Inc Earnings Call TranscriptNov 02, 2023$2.4 (+0.84%)Earnings
- Cellectar Biosciences Inc Annual Shareholders Meeting TranscriptJun 23, 2023
- Cellectar Biosciences Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 14, 2023
- Cellectar Biosciences Inc at ROTH Conference TranscriptMar 13, 2023
- Cellectar Biosciences Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) TranscriptSep 20, 2021
- Cellectar Biosciences Inc at Ladenburg Thalmann Virtual Healthcare Conference TranscriptJul 14, 2021
- Cellectar Biosciences Inc at Next Generation Targeted Cancer Therapies - The Cellectar Story! TranscriptOct 16, 2020
Cellectar Biosciences Inc at Ladenburg Thalmann Virtual Healthcare Conference Transcript
(Audio in progress) Cellectar Biosciences presentation. From the Company, we have the CEO and the President, James Caruso. Jim, thank you so much for joining us today. Really appreciate your time. I will turn it over to you for your presentation. If time allows, I'll ask a couple of questions, and you can take it over for your presentation. Thank you.
All right, terrific. Thank you, Dr. Demir, and certainly good afternoon to all. I thank you for your interest in Cellectar Biosciences and obviously your participation in this presentation. Cellectar is traded on the Nasdaq exchange under the ticker symbol CLRB. Here you can see the obligatory Safe Harbor statement. Of course, I also direct you to our SEC filings.
On slide 3, you can view the presentation topics. Today I will provide a general overview with a focus on our lead asset, which is CLR 131 for adult hematology indications.
Slide 4 is our company overview.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)